Yue Zhao, MD
Glaucoma Specialist · Berkeley, CANPI 1851753354
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Alcon accounts for 61.5% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $383, 8.9 times the $43 reported in 2020. That places this record below the midpoint for glaucoma specialist clinicians in CA, where the typical reported total is $4,143.
Across 24 payments — averaging $49.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$736
- Ivantis, Inc$148
- Bausch & Lomb Americas Inc.$114
- Sight Sciences, Inc.$76
- Sun Pharmaceutical Industries Inc.$38
- Oyster Point Pharma, Inc.$26
- plus $58 from 3 others
What the payments were for
- Food & beverage$1,196100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 10 | $736 |
| Ivantis, Inc | 1 | $148 |
| Bausch & Lomb Americas Inc. | 5 | $114 |
| Sight Sciences, Inc. | 2 | $76 |
| Sun Pharmaceutical Industries Inc. | 2 | $38 |
| Oyster Point Pharma, Inc. | 1 | $26 |
| Glaukos Corporation | 1 | $25 |
| Tarsus Pharmaceuticals, Inc. | 1 | $18 |
| Thea Pharma Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hydrus Microstent$417
- Constellation$154
- Clareon$124
How this compares
$1,196 in reported general payments places this provider in the 20th percentile of 64 glaucoma specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Timolol Maleate | 20 | $492 |
| Azelastine Hcl | 12 | $397 |
| ErythromycinErythromycin Base | 41 | $381 |
| Latanoprost | 45 | $213 |
Paid to pharmacies, not to this prescriber.
Other glaucoma specialist in Berkeley
- Jason BacharachPetaluma$1.7M
- Billy PanBeverly Hills$250K
- Jacob BrubakerSacramento$229K
- Felise May BarteSanta Clara$121K
- Houman VosoghiWestlake Village$119K
- Robert ChangStanford$105K
- Sophia WangStanford$77K
- Jeffrey GoldbergStanford$57K
- Valentina LozanoCulver City$51K
- Sameh MosaedIrvine$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.